Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Furosemide for Postpartum Blood Pressure
NCT03556761Phase 2Completed
- Sponsor
- University of Pennsylvania
- Start
- Jun 2018
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in hypertension (HTN) comparing Oral furosemide with Placebo (2 arms). Primary endpoints: Persistently Elevated Blood Pressures 7 Days Postpartum and Time to Resolution at 14 days. Started Jun 2018; status: completed.
02
Drugs
furosemide
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT03556761.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03556761.